Abstract
Glial cell derived neurotrophic factor (GDNF) holds promises for treating neurodegenerative diseases such as Parkinson’s disease. Human neural stem cells (hNSCs) have proved to be a suitable cell delivery vehicle for the safe and efficient introduction of GDNF into the brain. In this study, we used hNSCs-infected with a lentivirus encoding GDNF and the hygromycin resistance gene as such vehicles. A modified tetracycline operator 7 (tetO7) was inserted into a region upstream of the EF1-α promoter to drive GDNF expression. After hygromycin selection, hNSCs were infected with a lentivirus encoding a KRAB-tetracycline repressor fusion protein (TTS). TTS bound to tetO7 and suppressed the expression of GDNF in hNSCs. Upon administration of doxycycline (Dox) the TTS-tetO7 complex separated and the expression of GDNF resumed. The hNSCs infected with GDNF expressed the neural stem cell specific markers, nestin and sox2, and exhibited no significant change in proliferation rate. However, the rate of apoptosis in hNSCs expressing GDNF was lower compared with normal NSCs in response to actinomycin treatment. Furthermore, a higher percentage of Tuj-1 positive cells were obtained from GDNF-producing NSCs under conditions that induced differentiation compared to control NSCs. The inducible expression of GDNF in hNSCs may provide a system for the controllable delivery of GDNF in patients with neurodegenerative diseases.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lin L F, Doherty D H, Lile J D, et al. GDNF: a glial cell line-derived neurotrophicn factor midbrain dopaminergic neurons. Science, 1993, 260: 1130–1132
Kordower J H, Emborg M E, Bloch J, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science, 2000, 290: 767–773
Gill S S, Patel N K, Hotton G R, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med, 2003, 9: 589–595
Svendsen C N, Clarke D J, Rosser A E, et al. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp Neurol, 1996, 137: 376–388
Carpenter M K, Cui X, Hu Z Y, et al. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol, 1999, 158: 265–278
Svendsen C N, Caldwell L M A, Shen J, et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson’s disease. Exp Neurol, 1997, 148: 135–146
Klein S M, Behrstock S, McHugh J, et al. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res, 2002, 69: 955–965
Klein S M, Behrstock S, McHugh J, et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther, 2005, 16: 509–521
Behrstock S, Ebert A, McHugh J, et al. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther, 2006, 13: 379–388
Georgievska B, Kirik D, Bjorklund A, et al. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp Neurol, 2002, 177: 461–474
Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science, 1995, 268: 1766–1769
Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA, 1992, 89: 5547–5551
Koponen J K, Kankkonen H, Kannasto J, et al. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther, 2003, 10: 459–466
Zhou B Y, Ye Z H, Gao P, et al. Inducible and reversible transgene expression in human stem cells stably transduced by novel lentiviral vectors. Stem cells, 2006, 25: 779–789
Kirik D, Georgievska B, Bjorklund A, et al. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci, 2004, 7: 105–110
Judith F M, Josh R F, Wolfram K H, et al. Kruppel-associated boxes are potent transcriptionalrepression domains. Proc Natl Acad Sci USA, 1994, 91: 4509–4513
Deuschle U, Meyer W K, Thiesen H J. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol, 1995, 15: 1907–1914
Moosmann P, Georgiev O, Thiesen H J, et al. Silencing of RNA polymerases II and III-dependent transcription by the KRAB protein domain of KOX1, a Krüppel-type zinc finger factor. Biol Chem, 1997, 378: 669–678
Kafri T, van Praag H, Gage F H, et al. Lentiviral vectors: regulated gene expression. Mol Ther, 2000, 1: 516–521
Mark A K, Joseph C G, Luigi N. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med, 2001, 7: 33–40
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Wang, S., Ren, P., Guan, Y. et al. Inducible regulation of GDNF expression in human neural stem cells. Sci. China Life Sci. 56, 32–39 (2013). https://doi.org/10.1007/s11427-012-4424-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-012-4424-6